SCHEMBL22872467

SCHEMBL22872467

C/C=C(\C)CCc1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 2/20 0.50
▸ HRH3 Q9Y5N1 1/20 0.50
▸ ALDH1A1 P00352 3/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TAAR1 Q96RJ0 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ CYP1A2 P05177 6/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TSHR P16473 1/20 0.44
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ APP P05067 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28632625 0.81 ALDH1A1 (0.46) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL2722250 0.79 ALDH1A1 (0.57) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL21872596 0.79 HRH1 (0.52) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL21547665 0.79 HRH3 (0.41) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL23587146 0.78 HRH3 (0.44) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL1760709 0.76 HRH1 (0.52) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL1760708 0.76 HRH1 (0.52) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL18901920 0.75 HRH3 (0.47) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL230753 0.75 HRH1 (0.73) HRH1HRH3ALDH1A1LMNATAAR1
SCHEMBL29485678 0.75 HRH1 (0.73) HRH1HRH3ALDH1A1LMNATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262047-B1 IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME SK BIOPHARMACEUTICALS CO LTD (KR) 2021-01-06 — — EP disclosed
Send feedback